University of California researchers saw better muscle and cognitive function in older mice on semaglutide. The Motley Fool argues it is good news for Novo and Lilly stock.
Recap by typeshit. Full story at The Motley Fool.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
The group's letter to the acting FDA commissioner says all favorable votes on BPC-157, TB-500 and others came from newly appointed members.
A French clip flags dry mouth and reflux in GLP-1 patients, plus a specific risk to watch for before sedation.
Loading…